Ducati’s two-time MotoGP World Champion at the wheel of the V8 HPEV: “Reaching 10,000 rpm is incredible”
Sant’Agata Bolognese, 30 May 2025 – With three World Championships (including the 2022 and 2023 MotoGP titles) to his name, along with 40 wins and 78 podium finishes, Francesco ‘Pecco’ Bagnaia is one of the most successful riders in Grand Prix motorcycle racing. The lucky number 63 on his Ducati Desmosedici GP ties the rider from Turin together with Lamborghini, which was founded in 1963. Bagnaia is a big fan of the super sports cars from Sant’Agata Bolognese, so he seized the chance to be one of the first to take the wheel of the new Temerario[1] High Performance Electrified Vehicle (HPEV) with a new twin-turbo Lamborghini V8 engine that can reach 10,000 rpm.
Like a racing motorbike, it feels like it can keep pushing more and more: “I’d never felt anything like it. Rather than a turbo, it almost feels like it has a naturally aspirated engine with an enhanced intake. Reaching 10,000 rpm is incredible. I was astounded not only by that, but also by how easy it is to drive. It makes for a stunning combination.”’
Bagnaia also appreciated the outstanding performance of the Temerario. Delivering 920 CV thanks to its V8 twin-turbo engine paired with three electric motors, it can go from 0 to 100 km/h in just 2.7 seconds and from 0 to 200 km/h in 7.1 seconds, reaching a top speed of 343 km/h.
[1] The vehicle is not yet offered for sale and is therefore not subject to Directive 1999/94/EC. The fuel consumption and emissions data is in the type approval stage
Kia PV5 Cargo earns the top five-star rating in the 2025 Euro NCAP Commercial Van…
New campaign highlights Kia’s commitment to promoting unity and connection for people around the worldKia…
In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine…
BENGALURU, India, Dec. 8, 2025 /PRNewswire/ -- Parkinson's disease often begins far more quietly than…
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction…
TOKYO, Dec. 8, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment…